Bimosiamose (TBC 1269) (Synonyms: TBC 1269) |
Catalog No.GC33908 |
La bimosiamosa (TBC 1269) (TBC-1269) es un antagonista de pan-selectina no oligosacÁrido con IC50 de 88 μM, 20 μM y 86 μM para E-selectina, P-selectina y L-selectina, respectivamente .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 187269-40-5
Sample solution is provided at 25 µL, 10mM.
Bimosiamose is a pan-selectin antagonist, inhibits E-, P-, and L-selectin with IC50s of 88 μM, 20 μM, and 86 μM, respectively, and can be used in the research of inflammatory disease.
Bimosiamose is a pan-selectin antagonist, inhibits E-, P-, and L-selectin with IC50s of 88 μM, 20 μM, and 86 μM, respectively, and can be used in the research of inflammatory disease[1].
Bimosiamose (25 mg/kg, i.v.) significantly improves the survival in rats subjected to severe hepatic ischemia and reperfusion. Bimosiamose also causes lower ALT enzyme levels and decreases neutrophil infiltration[1].
[1]. Palma-Vargas JM, et al. Small-molecule selectin inhibitor protects against liver inflammatory response after ischemia and reperfusion. J Am Coll Surg. 1997 Oct;185(4):365-72.
Average Rating: 5
(Based on Reviews and 10 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *